CD8A and neoplasm: Concordantly, peripheral and tumor infiltrated CD8+T cells (Supplementary Fig. S4c), as well as GMZB+CD8T and IFNγ+CD8T were increased by HB3089 treatment (Fig. 1m, n), suggesting the activation of antitumor immunity.